These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 27396868)

  • 1. Effects of chronic l-theanine administration in patients with major depressive disorder: an open-label study.
    Hidese S; Ota M; Wakabayashi C; Noda T; Ozawa H; Okubo T; Kunugi H
    Acta Neuropsychiatr; 2017 Apr; 29(2):72-79. PubMed ID: 27396868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of L-Theanine Administration on Stress-Related Symptoms and Cognitive Functions in Healthy Adults: A Randomized Controlled Trial.
    Hidese S; Ogawa S; Ota M; Ishida I; Yasukawa Z; Ozeki M; Kunugi H
    Nutrients; 2019 Oct; 11(10):. PubMed ID: 31623400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-theanine in the adjunctive treatment of generalized anxiety disorder: A double-blind, randomised, placebo-controlled trial.
    Sarris J; Byrne GJ; Cribb L; Oliver G; Murphy J; Macdonald P; Nazareth S; Karamacoska D; Galea S; Short A; Ee C; Birling Y; Menon R; Ng CH
    J Psychiatr Res; 2019 Mar; 110():31-37. PubMed ID: 30580081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychotropic effects of
    Lopes Sakamoto F; Metzker Pereira Ribeiro R; Amador Bueno A; Oliveira Santos H
    Pharmacol Res; 2019 Sep; 147():104395. PubMed ID: 31412272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the effects of extended release quetiapine fumarate monotherapy on sleep disturbance in patients with major depressive disorder: a pooled analysis of four randomized acute studies.
    Trivedi MH; Bandelow B; Demyttenaere K; Papakostas GI; Szamosi J; Earley W; Eriksson H
    Int J Neuropsychopharmacol; 2013 Sep; 16(8):1733-44. PubMed ID: 23673347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. l-theanine adjunct to sertraline for major depressive disorder: A randomized, double-blind, placebo-controlled clinical trial.
    Shamabadi A; Kafi F; Arab Bafrani M; Asadigandomani H; A Basti F; Akhondzadeh S
    J Affect Disord; 2023 Jul; 333():38-43. PubMed ID: 37084960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of adjunct extended-release quetiapine fumarate on sleep disturbance and quality in patients with major depressive disorder and an inadequate response to on-going antidepressant therapy.
    Bauer M; McIntyre RS; Szamosi J; Eriksson H
    Int J Neuropsychopharmacol; 2013 Sep; 16(8):1755-65. PubMed ID: 23672772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of extended release quetiapine fumarate monotherapy in elderly patients with major depressive disorder: secondary analyses in subgroups of patients according to baseline anxiety, sleep disturbance, and pain levels.
    Montgomery SA; Altamura AC; Katila H; Datto C; Szamosi J; Eriksson H
    Int Clin Psychopharmacol; 2014 Mar; 29(2):93-105. PubMed ID: 24162081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of L-theanine (Suntheanine®) on objective sleep quality in boys with attention deficit hyperactivity disorder (ADHD): a randomized, double-blind, placebo-controlled clinical trial.
    Lyon MR; Kapoor MP; Juneja LR
    Altern Med Rev; 2011 Dec; 16(4):348-54. PubMed ID: 22214254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of anxiety symptoms on improvement of neurocognitive functions in patients with major depressive disorder: A 12-week, multicenter, randomized trial of tianeptine versus escitalopram, the CAMPION study.
    Yoo I; Woo JM; Lee SH; Fava M; Mischoulon D; Papakostas GI; Kim EJ; Chung S; Ha JH; Jeon HJ
    J Affect Disord; 2015 Oct; 185():24-30. PubMed ID: 26142691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of l-Theanine on Cognitive Function in Middle-Aged and Older Subjects: A Randomized Placebo-Controlled Study.
    Baba Y; Inagaki S; Nakagawa S; Kaneko T; Kobayashi M; Takihara T
    J Med Food; 2021 Apr; 24(4):333-341. PubMed ID: 33751906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of L-theanine on glutamatergic function in patients with schizophrenia.
    Ota M; Wakabayashi C; Sato N; Hori H; Hattori K; Teraishi T; Ozawa H; Okubo T; Kunugi H
    Acta Neuropsychiatr; 2015 Oct; 27(5):291-6. PubMed ID: 25896423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association between health related quality of life and severity of depression in patients with major depressive disorder].
    Cao Y; Li W; Shen J; Zhang Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Feb; 36(2):143-8. PubMed ID: 21368424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The acute effects of L-theanine in comparison with alprazolam on anticipatory anxiety in humans.
    Lu K; Gray MA; Oliver C; Liley DT; Harrison BJ; Bartholomeusz CF; Phan KL; Nathan PJ
    Hum Psychopharmacol; 2004 Oct; 19(7):457-65. PubMed ID: 15378679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of brain-derived neurotrophic factor and cortisol to sulfate of dehydroepiandrosterone molar ratio associated with clinical response to L-theanine as augmentation of antipsychotic therapy in schizophrenia and schizoaffective disorder patients.
    Miodownik C; Maayan R; Ratner Y; Lerner V; Pintov L; Mar M; Weizman A; Ritsner MS
    Clin Neuropharmacol; 2011; 34(4):155-60. PubMed ID: 21617527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: an open label study.
    Akkaya C; Sivrioglu EY; Akgoz S; Eker SS; Kirli S
    Hum Psychopharmacol; 2006 Jul; 21(5):337-45. PubMed ID: 16856215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial.
    Liebowitz M; Lam RW; Lepola U; Datto C; Sweitzer D; Eriksson H
    Depress Anxiety; 2010 Oct; 27(10):964-76. PubMed ID: 20734365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liraglutide promotes improvements in objective measures of cognitive dysfunction in individuals with mood disorders: A pilot, open-label study.
    Mansur RB; Ahmed J; Cha DS; Woldeyohannes HO; Subramaniapillai M; Lovshin J; Lee JG; Lee JH; Brietzke E; Reininghaus EZ; Sim K; Vinberg M; Rasgon N; Hajek T; McIntyre RS
    J Affect Disord; 2017 Jan; 207():114-120. PubMed ID: 27721184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neurobiological effects of theanine and its possible use in neurology and psychiatry].
    Katasonov AB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(11):118-124. PubMed ID: 30585616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Stress, Behavioural and Magnetoencephalography Effects of an L-Theanine-Based Nutrient Drink: A Randomised, Double-Blind, Placebo-Controlled, Crossover Trial.
    White DJ; de Klerk S; Woods W; Gondalia S; Noonan C; Scholey AB
    Nutrients; 2016 Jan; 8(1):. PubMed ID: 26797633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.